Guggenheim Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,553
Closed -$148K 1924
2022
Q4
$148K Buy
23,553
+6,630
+39% +$46.3K ﹤0.01% 1845
2022
Q3
$117K Sell
16,923
-505
-3% -$3.51K ﹤0.01% 1836
2022
Q2
$146K Buy
17,428
+5,769
+49% +$80.6K ﹤0.01% 1984
2022
Q1
$266K Sell
11,659
-5,713
-33% -$140K ﹤0.01% 1931
2021
Q4
$480K Buy
17,372
+6,875
+65% +$184K ﹤0.01% 1700
2021
Q3
$292K Buy
10,497
+2,019
+24% +$57.3K ﹤0.01% 1921
2021
Q2
$249K Buy
+8,478
New +$257K ﹤0.01% 2082
2020
Q4
Sell
-14,393
Closed -$224K 2048
2020
Q3
$224K Sell
14,393
-7,188
-33% -$124K ﹤0.01% 1740
2020
Q2
$395K Buy
+21,581
New +$380K ﹤0.01% 1520
2020
Q1
Sell
-12,546
Closed -$375K 1856
2019
Q4
$375K Buy
12,546
+532
+4% +$13.8K ﹤0.01% 1722
2019
Q3
$263K Sell
12,014
-3,661
-23% -$83.8K ﹤0.01% 1900
2019
Q2
$395K Sell
15,675
-7,744
-33% -$184K ﹤0.01% 1759
2019
Q1
$578K Sell
23,419
-3,790
-14% -$90.5K ﹤0.01% 1613
2018
Q4
$503K Sell
27,209
-2,738
-9% -$65.1K ﹤0.01% 1672
2018
Q3
$769K Buy
29,947
+10,510
+54% +$241K 0.01% 1756
2018
Q2
$452K Sell
19,437
-8,074
-29% -$167K ﹤0.01% 2004
2018
Q1
$438K Buy
27,511
+9,127
+50% +$170K ﹤0.01% 2416
2017
Q4
$382K Sell
18,384
-16,271
-47% -$258K ﹤0.01% 2427
2017
Q3
$497K Buy
34,655
+2,657
+8% +$40.2K ﹤0.01% 2389
2017
Q2
$553K Buy
31,998
+9,213
+40% +$110K ﹤0.01% 2370
2017
Q1
$251K Buy
22,785
+5,245
+30% +$72.2K ﹤0.01% 2579
2016
Q4
$255K Buy
17,540
+2,752
+19% +$50.5K ﹤0.01% 2638
2016
Q3
$363K Sell
14,788
-616
-4% -$15.9K ﹤0.01% 2500
2016
Q2
$310K Sell
15,404
-16,647
-52% -$471K ﹤0.01% 2530
2016
Q1
$842K Buy
32,051
+9,996
+45% +$739K ﹤0.01% 2154
2015
Q4
$2.24M Buy
22,055
+3,857
+21% +$433K 0.01% 1538
2015
Q3
$3.25M Sell
18,198
-9,955
-35% -$2.32M 0.01% 1275
2015
Q2
$6.25M Buy
28,153
+5,135
+22% +$1.14M 0.02% 1051
2015
Q1
$4.57M Sell
23,018
-2,700
-10% -$479K 0.01% 1204
2014
Q4
$3.68M Buy
25,718
+7,898
+44% +$1.06M 0.01% 1299
2014
Q3
$2.34M Buy
17,820
+1,770
+11% +$211K 0.01% 1647
2014
Q2
$2.02M Sell
16,050
-3,450
-18% -$440K 0.01% 1812
2014
Q1
$2.57M Buy
19,500
+5,660
+41% +$774K 0.01% 1576
2013
Q4
$1.63M Sell
13,840
-7,130
-34% -$781K ﹤0.01% 1938
2013
Q3
$2.19M Sell
20,970
-15,490
-42% -$1.51M 0.01% 1557
2013
Q2
$3.2M Buy
+36,460
New +$2.87M 0.01% 1269

Other funds holding BHC

Guggenheim Capital's BHC Position: Q1 2023 in Review

Guggenheim Capital sold out of Bausch Health (BHC) in Q1 2023, closing a stake of 23,553 shares — an estimated $148K sold.

Guggenheim Capital first reported a position in BHC in Q2 2013 and held it in 36 quarters. The position peaked at $6.25M in Q2 2015. 235 funds tracked by Wall St. Rank hold BHC as of Q1 2023.

  • Guggenheim Capital reported no remaining Bausch Health position as of Q1 2023 after selling out during the quarter.
  • Guggenheim Capital sold 23,553 Bausch Health shares in Q1 2023, an estimated $148K.
  • Guggenheim Capital first reported a position in Bausch Health in Q2 2013 and held it in 36 quarters.
  • Guggenheim Capital's Bausch Health position peaked at $6.25M in Q2 2015.
  • 235 funds tracked by Wall St. Rank held Bausch Health as of Q1 2023.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.